Genvoya Approved for Treatment of HIV
New Drugs , News / October 7, 2016

The FDA approved Genvoya (fixed-dose combination tablet containing elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide) as a complete regimen for treatment of HIV-1 infection in adults and pediatric patients 12 years of age and olde...

Skip to toolbar